BIO KOREA 2020 Invest Fair Neuroventi
페이지 정보
조회 1,029회
작성일 20-07-01
본문
BIO KOREA 2020 Invest Fair Neuroventi
20-07-01
At the BIO KOREA 2020 Invest Fair, Shin Chan-young, CEO of Neuroventi, introduces autism and the development of therapeutic agents for treatment.
Neuroventi Co., Ltd. was established in 2015 by CEO Chan-Young Shin, and is currently in pre-clinical development to develop a treatment for autism spectrum disorder. do